chr3-141487069-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000286364(RASA2):c.-15G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000682 in 1,261,912 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000073 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000067 ( 0 hom. )
Consequence
RASA2
ENST00000286364 5_prime_UTR
ENST00000286364 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.773
Genes affected
RASA2 (HGNC:9872): (RAS p21 protein activator 2) The protein encoded by this gene is member of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RASA2 | NM_006506.5 | c.-15G>C | 5_prime_UTR_variant | 1/24 | ENST00000286364.9 | NP_006497.2 | ||
RASA2 | NM_001303246.3 | c.-15G>C | 5_prime_UTR_variant | 1/25 | NP_001290175.1 | |||
RASA2 | NM_001303245.3 | c.-15G>C | 5_prime_UTR_variant | 1/24 | NP_001290174.1 | |||
RASA2 | XM_047448652.1 | c.-15G>C | 5_prime_UTR_variant | 1/17 | XP_047304608.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RASA2 | ENST00000286364 | c.-15G>C | 5_prime_UTR_variant | 1/24 | 1 | NM_006506.5 | ENSP00000286364.3 | |||
RASA2 | ENST00000515549.1 | n.-15G>C | non_coding_transcript_exon_variant | 1/5 | 4 | ENSP00000424293.1 | ||||
RASA2 | ENST00000515549.1 | n.-15G>C | 5_prime_UTR_variant | 1/5 | 4 | ENSP00000424293.1 |
Frequencies
GnomAD3 genomes AF: 0.0000733 AC: 11AN: 150044Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
11
AN:
150044
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000634 AC: 1AN: 15774Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 8412
GnomAD3 exomes
AF:
AC:
1
AN:
15774
Hom.:
AF XY:
AC XY:
0
AN XY:
8412
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000675 AC: 75AN: 1111868Hom.: 0 Cov.: 30 AF XY: 0.0000668 AC XY: 36AN XY: 538734
GnomAD4 exome
AF:
AC:
75
AN:
1111868
Hom.:
Cov.:
30
AF XY:
AC XY:
36
AN XY:
538734
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000733 AC: 11AN: 150044Hom.: 0 Cov.: 32 AF XY: 0.0000273 AC XY: 2AN XY: 73230
GnomAD4 genome
AF:
AC:
11
AN:
150044
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
73230
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 01, 2019 | Variant summary: RASA2 c.-15G>C is located in the untranslated mRNA region upstream of the initiation codon. The variant allele was found at a frequency of 6.3e-05 in 15774 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.-15G>C in individuals affected with Noonan Syndrome and Related Conditions and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at